Escitalopram (Lexapro)
Escitalopram (Lexapro) is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
Escitalopram Treatment of Patients With Agitated Dementia
Clinical Pharmacogenomics of Antidepressant Response
Lexapro in the Treatment of Patients With Postpartum Depression
Clinical Trials (6)
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
Escitalopram Treatment of Patients With Agitated Dementia
Clinical Pharmacogenomics of Antidepressant Response
Lexapro in the Treatment of Patients With Postpartum Depression
Escitalopram as a Mood Stabilizer for Bipolar II Disorder
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6